LivingGLP1
Study S002505

Identifying Undiagnosed HFpEF Among Patients With Type 2 Diabetes Using Ultromics AI HFpEF Algorithm

Registration

Registration
NCT06593314
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
RECRUITING
Enrollment
800
Start
2025-08-06
Primary completion
2026-09-15
Lead sponsor
University of Texas Southwestern Medical Center
Conditions
Heart Failure; Diabetes
Interventions
BEHAVIORAL:Message with EchoGo; BEHAVIORAL:Standard Message
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Frequency of prescription of SGLT-2i medication at outpatient clinic visits over 3 months follow-up [3-month follow-up]
  • Frequency of prescription of SGLT-2i medication at outpatient clinic visits over 6 months follow-up [3-month follow-up]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.